NYSE:BHC Bausch Health Cos (BHC) Stock Price, News & Analysis $6.46 +0.04 (+0.55%) Closing price 10/21/2026 03:59 PM EasternExtended Trading$6.44 -0.01 (-0.17%) As of 06:46 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Bausch Health Cos Stock (NYSE:BHC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Bausch Health Cos alerts:Sign Up Key Stats Today's Range$6.29▼$6.5250-Day Range$5.64▼$6.9452-Week Range$4.33▼$8.00Volume2.03 million shsAverage Volume1.83 million shsMarket Capitalization$2.42 billionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingHold Company Overview Bausch Health Companies Inc. (NYSE:BHC) is a multinational specialty pharmaceutical company focused on developing, manufacturing and commercializing branded, generic and over-the-counter medicines. Its portfolio serves several therapeutic areas, including gastroenterology, dermatology, neurology, ophthalmology, hospital products and other specialty-care markets. The company markets products through businesses such as Salix Pharmaceuticals, Ortho Dermatologics, Solta Medical and its international pharmaceutical operations. Its products are sold in the United States and internationally through a combination of direct commercial operations, distributors and strategic partners. Bausch Health was previously known as Valeant Pharmaceuticals International and adopted its current name in 2018. In 2022, it separated its eye-care business, Bausch + Lomb, into a separately traded public company. Bausch Health is headquartered in Laval, Quebec, and is led by Chief Executive Officer Thomas J. Appio.AI Generated. May Contain Errors. Read More Bausch Health Cos Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreBHC MarketRank™: 2.516680010675 of 5 starsBausch Health Cos scored higher than 50% of companies evaluated by MarketBeat, and ranked 500th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingBausch Health Cos has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on 1 strong buy rating, no buy ratings, 5 hold ratings, and 1 sell rating.Upside PotentialBausch Health Cos has a consensus price target of $8.00, representing about 23.9% upside from its current price of $6.46.Amount of Analyst CoverageBausch Health Cos has only been the subject of 3 research reports in the past 90 days.Read more about Bausch Health Cos' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-7.59% Earnings GrowthEarnings for Bausch Health Cos are expected to decrease by -7.59% in the coming year, from $4.35 to $4.02 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Bausch Health Cos is -2.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bausch Health Cos is -2.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBausch Health Cos has a P/B Ratio of 6.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Bausch Health Cos' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.83% of the float of Bausch Health Cos has been sold short.Short Interest Ratio / Days to CoverBausch Health Cos has a short interest ratio ("days to cover") of 4.83.Change versus previous monthShort interest in Bausch Health Cos has recently decreased by 2.59%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBausch Health Cos does not currently pay a dividend.Dividend GrowthBausch Health Cos does not have a long track record of dividend growth. News and Social Media2.0 / 5News Sentiment0.18 News SentimentBausch Health Cos has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Bausch Health Cos this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for BHC on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows1 people have added Bausch Health Cos to their MarketBeat watchlist in the last 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Bausch Health Cos insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $258,894.00 in company stock.Percentage Held by Insiders20.67% of the stock of Bausch Health Cos is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions78.65% of the stock of Bausch Health Cos is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Bausch Health Cos' insider trading history. Receive BHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bausch Health Cos and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BHC Stock News HeadlinesBausch Health Reports Expanded Public Reimbursement For Injectable Schizophrenia DrugOctober 20 at 9:01 AM | finance.yahoo.comBHC - Bausch Health Companies Inc.October 14, 2026 | seekingalpha.comIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest. A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this fall, one that could offer savings rates up to 6 percent. See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live.October 22 at 1:00 AM | Banyan Hill Publishing (Ad)Bausch Health Cos (NYSE:BHC) and Journey Medical (NASDAQ:DERM) Head to Head SurveyOctober 13, 2026 | americanbankingnews.comBausch Health : Lomb and Health Announce Appointment of Thomas J. Appio as Interim Lomb CEO, Expect to Raise Full-Year 2026 GuidanceOctober 12, 2026 | marketscreener.comMSix-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical PathwayOctober 12, 2026 | prnewswire.comBausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 GuidanceOctober 12, 2026 | businesswire.comBausch Health to Announce Third Quarter 2026 Results on October 28, 2026October 6, 2026 | prnewswire.comSee More Headlines BHC Stock Analysis - Frequently Asked Questions How have BHC shares performed this year? Bausch Health Cos' stock was trading at $6.95 at the start of the year. Since then, BHC shares have decreased by 7.1% and is now trading at $6.4550. How were Bausch Health Cos' earnings last quarter? Bausch Health Cos Inc. (NYSE:BHC) issued its quarterly earnings data on Wednesday, July, 29th. The company reported $1.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.96 by $0.30. The business had revenue of $2.83 billion for the quarter, compared to the consensus estimate of $2.59 billion. Bausch Health Cos had a negative net margin of 10.12% and a negative trailing twelve-month return on equity of 561.95%. Read the conference call transcript. Who are Bausch Health Cos' major shareholders? Bausch Health Cos' top institutional investors include Sanders Morris Harris LLC (0.01%), TD Waterhouse Canada Inc. and Roxbury Financial LLC. Insiders that own company stock include John Paulson, Seana Carson, Aimee J Lenar and Frank D Lee. View institutional ownership trends. How do I buy shares of Bausch Health Cos? Shares of BHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Bausch Health Cos own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Cos investors own include Gilead Sciences (GILD), NVIDIA (NVDA), Micron Technology (MU), Advanced Micro Devices (AMD), Tesla (TSLA), Alibaba Group (BABA) and Bank of America (BAC). Company Calendar Last Earnings7/29/2026Today10/22/2026Next Earnings (Estimated)10/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 BHC's financial health is in the Green zone, according to TradeSmith. BHC has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:BHC CIK885590 Webwww.bauschhealth.com Phone(514) 744-6792Fax514-744-6272Employees20,300Year Founded1959Price Target and Rating Average Price Target for Bausch Health Cos$8.00 High Price Target$9.00 Low Price Target$7.00 Potential Upside/Downside+23.9%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($2.96) Trailing P/E RatioN/A Forward P/E Ratio1.48 P/E GrowthN/ANet Income$157 million Net Margins-10.12% Pretax Margin-6.74% Return on Equity-561.95% Return on Assets6.31% Debt Debt-to-Equity RatioN/A Current Ratio1.44 Quick Ratio1.08 Sales & Book Value Annual Sales$10.27 billion Price / Sales0.24 Cash Flow$7.34 per share Price / Cash Flow0.88 Book Value$1.02 per share Price / Book6.33Miscellaneous Outstanding Shares374,380,000Free Float296,998,000Market Cap$2.42 billion OptionableOptionable Beta0.37 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NYSE:BHC) was last updated on 10/21/2026 by MarketBeat.com Staff. From Our PartnersMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | Sponsored80 Days Until the Pentagon Restricts Chinese Rare EarthsChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Cos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Cos With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
